These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9783782)

  • 1. Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes.
    Roayaie S; Guarrera JV; Ye MQ; Thung SN; Emre S; Fishbein TM; Guy SR; Sheiner PA; Miller CM; Schwartz ME
    J Am Coll Surg; 1998 Oct; 187(4):365-72. PubMed ID: 9783782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes.
    Weber SM; Jarnagin WR; Klimstra D; DeMatteo RP; Fong Y; Blumgart LH
    J Am Coll Surg; 2001 Oct; 193(4):384-91. PubMed ID: 11584966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma.
    Kawarada Y; Yamagiwa K; Das BC
    Am J Surg; 2002 Jun; 183(6):679-85. PubMed ID: 12095601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognosis of 84 intrahepatic cholangiocarcinoma patients].
    Li FH; Chen XQ; Luo HY; Li YH; Wang F; Qiu MZ; Teng KY; Li ZH; Xu RH
    Ai Zheng; 2009 May; 28(5):528-32. PubMed ID: 19624884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients.
    Yedibela S; Demir R; Zhang W; Meyer T; Hohenberger W; Schönleben F
    Ann Surg Oncol; 2009 Feb; 16(2):404-12. PubMed ID: 19037702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of tumor localization on the outcomes of surgery for an intrahepatic cholangiocarcinoma.
    Orimo T; Kamiyama T; Mitsuhashi T; Kamachi H; Yokoo H; Wakayama K; Shimada S; Nagatsu A; Taketomi A
    J Gastroenterol; 2018 Nov; 53(11):1206-1215. PubMed ID: 29721628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period.
    Lang H; Sotiropoulos GC; Frühauf NR; Dömland M; Paul A; Kind EM; Malagó M; Broelsch CE
    Ann Surg; 2005 Jan; 241(1):134-43. PubMed ID: 15622001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections.
    Nagino M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Takahashi Y; Nimura Y
    Ann Surg; 2013 Jul; 258(1):129-40. PubMed ID: 23059502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapy.
    Kelley ST; Bloomston M; Serafini F; Carey LC; Karl RC; Zervos E; Goldin S; Rosemurgy P; Rosemurgy AS
    Am Surg; 2004 Sep; 70(9):743-8; discussion 748-9. PubMed ID: 15481288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahepatic cholangiocarcinoma. Results of aggressive surgical management.
    Cherqui D; Tantawi B; Alon R; Piedbois P; Rahmouni A; Dhumeaux D; Julien M; Fagniez PL
    Arch Surg; 1995 Oct; 130(10):1073-8. PubMed ID: 7575119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma.
    Dhanasekaran R; Hemming AW; Zendejas I; George T; Nelson DR; Soldevila-Pico C; Firpi RJ; Morelli G; Clark V; Cabrera R
    Oncol Rep; 2013 Apr; 29(4):1259-67. PubMed ID: 23426976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visceral infiltration of intrahepatic cholangiocarcinoma is most prognostic after curative resection - Retrospective cohort study of 102 consecutive liver resections from a single center.
    Bartsch F; Baumgart J; Hoppe-Lotichius M; Schmidtmann I; Heinrich S; Lang H
    Int J Surg; 2018 Jul; 55():193-200. PubMed ID: 29803768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
    Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
    Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables.
    Okabayashi T; Yamamoto J; Kosuge T; Shimada K; Yamasaki S; Takayama T; Makuuchi M
    Cancer; 2001 Nov; 92(9):2374-83. PubMed ID: 11745293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of combined hepatocelluar-cholangiocarcinoma and comparison with intrahepatic cholangiocarcinoma.
    Kim SH; Park YN; Lim JH; Choi GH; Choi JS; Kim KS
    Eur J Surg Oncol; 2014 Aug; 40(8):976-81. PubMed ID: 24909336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined hepatocellular-cholangiocarcinoma had poor outcomes after hepatectomy regardless of Allen and Lisa class or the predominance of intrahepatic cholangiocarcinoma cells within the tumor.
    Ariizumi S; Kotera Y; Katagiri S; Nakano M; Yamamoto M
    Ann Surg Oncol; 2012 May; 19(5):1628-36. PubMed ID: 22113592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment.
    Rayar M; Sulpice L; Edeline J; Garin E; Levi Sandri GB; Meunier B; Boucher E; Boudjema K
    Ann Surg Oncol; 2015 Sep; 22(9):3102-8. PubMed ID: 25623598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas.
    Kim YS; Oh SY; Go SI; Kang JH; Park I; Song HN; Ji JH; Hwang IG; Jang JS
    Cancer Chemother Pharmacol; 2017 Jan; 79(1):99-106. PubMed ID: 27928598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.